Regisry of the Stroke Patients in Assiut University Hospital

January 4, 2018 updated by: Noura Abdel hakim abdel Mohsen, Assiut University
• Aim of the work To register all type of acute stroke admitted in Assiut university Hospital and assessment of their risk factor, morbidity and Mortality

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

1

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients with stroke aged ≥18 years of both sex
  • Written consent was taken for all patient either from the patient himself of closes relative after explaning to them the type of treatment benefits and possible risks

Exclusion Criteria:

  • Stroke due to metabolic causes as hypoglycemia liver, Renal failure and other metabolic causes
  • Stroke due to Brain tumors

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: tissue plasmnogen activator
role of tissue plasminogen activator in patient with acute ischemic stroke having selective criteria for rTPA
Other Names:
  • rtpa
Active Comparator: thrombectoy
role of thrombectomy in patient with acute ischemic stroke

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Registry of the stroke Patients in Assist University Hospital
Time Frame: one year
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 30, 2018

Primary Completion (Anticipated)

December 30, 2018

Study Completion (Anticipated)

December 30, 2018

Study Registration Dates

First Submitted

December 14, 2017

First Submitted That Met QC Criteria

January 4, 2018

First Posted (Actual)

January 8, 2018

Study Record Updates

Last Update Posted (Actual)

January 8, 2018

Last Update Submitted That Met QC Criteria

January 4, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe